Stay updated on Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.

Latest updates to the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.3.3 to v3.3.4; it appears in the page footer as the site version. No study content or functionality changes were observed.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe Locations section was updated to add Illinois, Michigan, New York, Ohio, and Tennessee locations and remove the previous location blocks, with a revision tag indicating v3.3.3.SummaryDifference0.6%

- Check50 days agoChange DetectedThe page update shows an added Revision: v3.3.2 and a removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding status banner on the page was removed, reducing visibility of a maintenance notice; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedResults for NCT03242915 have been posted, including the primary endpoint (response rate) and secondary endpoints (progression-free survival and overall survival). The study record dates reflect updates and results submission in May 2025.SummaryDifference0.4%

- Check100 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. Overall, the page now communicates current operating status and version, indicating a substantive update.SummaryDifference4%

Stay in the know with updates to Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.